Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
180M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
37.3M
-
Shares change
-
+2.01M
-
Total reported value, excl. options
-
$440M
-
Value change
-
+$23.6M
-
Number of buys
-
28
-
Number of sells
-
-11
-
Price
-
$11.78
Significant Holders of Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA) as of Q1 2022
51 filings reported holding TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2022.
Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.3M shares
of 180M outstanding shares and own 20.7% of the company stock.
Largest 10 shareholders include Column Group LLC (9.4M shares), FMR LLC (6.19M shares), Casdin Capital, LLC (3.59M shares), RA CAPITAL MANAGEMENT, L.P. (3.55M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.03M shares), RTW INVESTMENTS, LP (2.46M shares), BlackRock Inc. (2.43M shares), VANGUARD GROUP INC (1.09M shares), Alphabet Inc. (916K shares), and Euclidean Capital LLC (916K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.